Precision Med TRI-CON 2024

The 31st International Precision Med TRI-CON 2024 will be held 26-28 March 2024 in San Diego, California.

Virtual participation is available as well as flexible registration to switch between in-person and virtual attendance across the conference.

Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and precision health; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including Multi-Cancer Early Detection and Minimal Residual Disease testing.

Emerging implications of faster and cheaper sequencing, AI and digital tools, and spatial biology and single-cell multiomics in advancing precision medicine will be covered in 2024.

Highlighted sessions and topics include:

• The Shifting Landscape of Respiratory Pathogen Testing
• Multiplex Testing for Respiratory Pathogens—What Is the Right Fit?
• Controlled Human Infection Models in Biomarker Development for Precision Medicine
• The Host Response in Acute Infections and Sepsis: Potential Challenges and Benefits
• Clinical Metagenomic Sequencing for Rapid Diagnosis of Infections
• Diagnostic Stewardship and Implementation of New Tests for Infectious Diseases in the Emergency Department
• Diagnosis of Invasive Fungal Infections by Microbial Metagenomics Sequencing
• Advancing the AI in Diagnostics and Healthcare: Role of the Public-Private Partnership Model
• Augmenting AI-Powered Clinician Decision Support Tools for Severe Infection
• Clinical Integration of Microbial Whole-Genome Sequencing
• High-Resolution Single-Cell and Spatial Technologies in Drug Development
• Home Testing for Infectious Diseases and Chronic Disease Monitoring
• Scalable Solutions for Antibody Development and Manufacturing
• Accelerating Patient-Centered Diagnostics by Bringing Innovative Molecular Technologies to Point-of-Care Testing
• At-Home Blood Microsampling: Innovations, Opportunities, and Challenges
• Direct Access Testing—What Can Be Done to Realize Its Full Potential?
• Advances in Mobile and Digital Technologies for Point-of-Care Diagnostics
• RADically Speeding the Development and Validation of POC and Home-Based Diagnostics at the NIH: Lessons Learned and Future Directions

Please visit Cambridge Healthtech Institute’s Precision Med TRI-CON 2024 event page for more information and to register.